These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 32916763)
1. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer. Morcos M; Antaki M; Viswanathan AN; Enger SA Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763 [TBL] [Abstract][Full Text] [Related]
2. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520 [TBL] [Abstract][Full Text] [Related]
3. A novel Famulari G; Duclos M; Enger SA Med Phys; 2020 Mar; 47(3):859-868. PubMed ID: 31828783 [TBL] [Abstract][Full Text] [Related]
4. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer. Morcos M; Viswanathan AN; Enger SA Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739 [TBL] [Abstract][Full Text] [Related]
5. Monte Carlo dosimetry study of novel rotating MRI-compatible shielded tandems for intensity modulated cervix brachytherapy. Morcos M; Enger SA Phys Med; 2020 Mar; 71():178-184. PubMed ID: 32163887 [TBL] [Abstract][Full Text] [Related]
6. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy. Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427 [TBL] [Abstract][Full Text] [Related]
7. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669 [TBL] [Abstract][Full Text] [Related]
8. Robitaille M; Ménard C; Famulari G; Béliveau-Nadeau D; Enger SA Brachytherapy; 2024; 23(5):523-534. PubMed ID: 39038997 [TBL] [Abstract][Full Text] [Related]
9. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study. Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455 [TBL] [Abstract][Full Text] [Related]
10. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732 [TBL] [Abstract][Full Text] [Related]
11. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy. Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131 [TBL] [Abstract][Full Text] [Related]
12. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT. Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016 [TBL] [Abstract][Full Text] [Related]
13. Integration of rotatable tandem applicator to conventional ovoid applicator toward complete framework of intensity modulated brachytherapy (IMBT) for cervical cancer. Kim H; Goh Y; Kim DW; Kim JS; Lim YK Phys Med; 2021 Nov; 91():131-139. PubMed ID: 34800907 [TBL] [Abstract][Full Text] [Related]
14. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study. Qu HD; Han DM; Zhang N; Mao Z; Cheng GH Front Oncol; 2020; 10():621347. PubMed ID: 33680943 [TBL] [Abstract][Full Text] [Related]
15. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer. Sharma M; Fields EC; Todor DA Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424 [TBL] [Abstract][Full Text] [Related]
16. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results. Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345 [TBL] [Abstract][Full Text] [Related]
17. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651 [TBL] [Abstract][Full Text] [Related]
18. Dynamic rotating-shield brachytherapy. Liu Y; Flynn RT; Kim Y; Yang W; Wu X Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489 [TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer. Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197 [TBL] [Abstract][Full Text] [Related]
20. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer. Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]